Access to the PDF text

Archives of cardiovascular diseases
Volume 111, n° 8-9
pages 497-506 (août 2018)
Doi : 10.1016/j.acvd.2017.10.007
Received : 27 June 2017 ;  accepted : 30 October 2017
Clinical research

French national survey on infective endocarditis and the Melody™ valve in percutaneous pulmonary valve implantation
Expérience nationale française sur endocardite infectieuse et valvulation pulmonaire percutanée par Mélody™

Figure 1

Figure 1 : 

Survival curves. A. Global infective endocarditis (IE) risk. B. IE risk before and after 2013. C. Survival curve comparing IE and non-IE groups (freedom from death). D. Survival curve comparing IE and non-IE groups (freedom from cardiovascular event and death). E. Global survival curve.

Figure 2

Figure 2 : 

Flow chart showing type of treatment and outcome of Melody valve infective endocarditis (IE). Ao: aortic; BMS: bare-metal stent; IV: intravenous; PR: pulmonary regurgitation; RVOTO: right ventricular outflow tract obstruction.* Patient with associated aortic insufficiency, who underwent aortic valve replacement and pulmonary valve replacement of the stented Melody valve.

EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Article Outline